Morgan Stanley’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-209,351
| Closed | -$11.6M | – | 6789 |
|
|
2017
Q1 | $11.6M | Buy |
209,351
+4,568
| +2% | +$229K | ﹤0.01% | 2055 |
|
|
2016
Q4 | $8.91M | Buy |
204,783
+100,156
| +96% | +$4.04M | ﹤0.01% | 2376 |
|
|
2016
Q3 | $4.1M | Sell |
104,627
-33,194
| -24% | -$1.19M | ﹤0.01% | 2862 |
|
|
2016
Q2 | $3.77M | Sell |
137,821
-4,754
| -3% | -$134K | ﹤0.01% | 2874 |
|
|
2016
Q1 | $3.87M | Sell |
142,575
-57,901
| -29% | -$1.37M | ﹤0.01% | 2764 |
|
|
2015
Q4 | $5.72M | Buy |
200,476
+61,763
| +45% | +$1.95M | ﹤0.01% | 2534 |
|
|
2015
Q3 | $4.44M | Sell |
138,713
-9,248
| -6% | -$306K | ﹤0.01% | 2759 |
|
|
2015
Q2 | $4.36M | Buy |
147,961
+39,367
| +36% | +$1.19M | ﹤0.01% | 2911 |
|
|
2015
Q1 | $3.35M | Buy |
108,594
+14,971
| +16% | +$479K | ﹤0.01% | 3125 |
|
|
2014
Q4 | $2.61M | Buy |
93,623
+46,264
| +98% | +$1.2M | ﹤0.01% | 3320 |
|
|
2014
Q3 | $1.07M | Sell |
47,359
-222,101
| -82% | -$4.4M | ﹤0.01% | 3974 |
|
|
2014
Q2 | $4.09M | Buy |
269,460
+13,459
| +5% | +$230K | ﹤0.01% | 2843 |
|
|
2014
Q1 | $5.02M | Buy |
256,001
+74,057
| +41% | +$1.44M | ﹤0.01% | 2580 |
|
|
2013
Q4 | $3.44M | Buy |
181,944
+142,498
| +361% | +$2.04M | ﹤0.01% | 2927 |
|
|
2013
Q3 | $355K | Buy |
+39,446
| New | +$293K | ﹤0.01% | 4567 |
|
Other funds holding ZLTQ
Morgan Stanley's ZLTQ Position: Q2 2017 in Review
Morgan Stanley sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 209,351 shares — an estimated $11.6M sold.
Morgan Stanley first reported a position in ZLTQ in Q3 2013 and held it in 15 quarters. The position peaked at $11.6M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.
- Morgan Stanley reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
- Morgan Stanley sold 209,351 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $11.6M.
- Morgan Stanley first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2013 and held it in 15 quarters.
- Morgan Stanley's ZELTIQ Aesthetics, Inc. position peaked at $11.6M in Q1 2017.
- 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.
Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.